U.S. markets open in 2 hours 57 minutes
  • S&P Futures

    4,291.25
    -7.00 (-0.16%)
     
  • Dow Futures

    33,830.00
    -43.00 (-0.13%)
     
  • Nasdaq Futures

    13,656.00
    -25.25 (-0.18%)
     
  • Russell 2000 Futures

    2,020.80
    -3.00 (-0.15%)
     
  • Crude Oil

    88.87
    -0.54 (-0.60%)
     
  • Gold

    1,790.10
    -8.00 (-0.44%)
     
  • Silver

    20.01
    -0.26 (-1.29%)
     
  • EUR/USD

    1.0136
    -0.0029 (-0.28%)
     
  • 10-Yr Bond

    2.7910
    0.0000 (0.00%)
     
  • Vix

    20.10
    +0.57 (+2.92%)
     
  • GBP/USD

    1.2029
    -0.0029 (-0.24%)
     
  • USD/JPY

    134.1140
    +0.8420 (+0.63%)
     
  • BTC-USD

    24,069.67
    -122.12 (-0.50%)
     
  • CMC Crypto 200

    572.46
    -18.30 (-3.10%)
     
  • FTSE 100

    7,547.89
    +38.74 (+0.52%)
     
  • Nikkei 225

    28,868.91
    -2.87 (-0.01%)
     

Is IN8bio (NASDAQ:INAB) In A Good Position To Deliver On Growth Plans?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.

Given this risk, we thought we'd take a look at whether IN8bio (NASDAQ:INAB) shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'.

Check out our latest analysis for IN8bio

Does IN8bio Have A Long Cash Runway?

A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In March 2022, IN8bio had US$32m in cash, and was debt-free. Looking at the last year, the company burnt through US$16m. That means it had a cash runway of about 2.0 years as of March 2022. That's not too bad, but it's fair to say the end of the cash runway is in sight, unless cash burn reduces drastically. You can see how its cash balance has changed over time in the image below.

debt-equity-history-analysis
debt-equity-history-analysis

How Is IN8bio's Cash Burn Changing Over Time?

Because IN8bio isn't currently generating revenue, we consider it an early-stage business. Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation. The skyrocketing cash burn up 101% year on year certainly tests our nerves. It's fair to say that sort of rate of increase cannot be maintained for very long, without putting pressure on the balance sheet. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company.

How Easily Can IN8bio Raise Cash?

Given its cash burn trajectory, IN8bio shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. Many companies end up issuing new shares to fund future growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations.

IN8bio's cash burn of US$16m is about 35% of its US$46m market capitalisation. That's not insignificant, and if the company had to sell enough shares to fund another year's growth at the current share price, you'd likely witness fairly costly dilution.

Is IN8bio's Cash Burn A Worry?

On this analysis of IN8bio's cash burn, we think its cash runway was reassuring, while its increasing cash burn has us a bit worried. We don't think its cash burn is particularly problematic, but after considering the range of factors in this article, we do think shareholders should be monitoring how it changes over time. Separately, we looked at different risks affecting the company and spotted 4 warning signs for IN8bio (of which 2 are concerning!) you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here